{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:00:24Z","timestamp":1780326024259,"version":"3.54.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Reduction mammaplasty is an effective treatment for symptomatic macromastia but is associated with postoperative complications, such as hematoma, seroma, and infection. Tranexamic acid (TXA) has been shown to reduce blood loss and hematoma formation across surgical specialties, whereas the efficacy of adjunctive topical agents like Arista, a microporous polysaccharide hemostat, remains uncertain in breast surgery. This study evaluates whether combining TXA with Arista confers additional benefit in reducing postoperative complications following reduction mammaplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort study was conducted on patients undergoing bilateral reduction mammaplasty at a single institution from January 1, 2020, to April 1, 2025. Patients were divided into 3 groups: those receiving both IV TXA and topical Arista (n\u2009=\u2009120), TXA alone (n\u2009=\u2009133), and neither agent (control, n\u2009=\u2009211). The primary outcome was hematoma incidence, stratified into major (requiring reoperation) and minor. Secondary outcomes included seroma, infection, and delayed wound healing. Statistical analyses included ANOVA and chi-squared tests with significance set at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 464 patients were included in this study; 120 consecutive breast reduction patients received both Arista and TXA, 133 patients received TXA only, and 211 controls received neither. Combined use of TXA and Arista resulted in the lowest total hematoma rate (2.5%), compared to TXA alone (3.8%) and control (10.0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Major hematoma rates were significantly reduced in both treatment groups compared to control but did not differ significantly between TXA (2.3%) and TXA\u2009+\u2009Arista (1.7%). Infection rates were lowest in the combination group (0.8%) versus TXA alone (6.8%) and control (2.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Delayed wound healing was also reduced with combined treatment (1.7%) compared to TXA alone (16.5%) and control (11.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.0005). Seroma rates and estimated blood loss showed no significant differences across groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IV TXA significantly reduces postoperative hematoma rates following reduction mammaplasty, with the addition of Arista providing a modest incremental benefit. Although TXA remains the primary agent for hematoma prophylaxis, Arista may be selectively useful in patients contraindicated for TXA. Further prospective studies are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sap.0000000000004586","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:00:19Z","timestamp":1765555219000},"page":"S455-S458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Use of Plant-Based Absorbable Hemostatic Powder and Intravenous Tranexamic Acid in Breast Reduction Patients Reduces Hematoma Rates"],"prefix":"10.1097","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0085-9574","authenticated-orcid":false,"given":"Anjali","family":"Om","sequence":"first","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hyun","family":"Kong","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orr","family":"Shauly","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cuzzone","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Garcia Nores","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Losken","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"bib1-20260601","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1090820X13515676","article-title":"Complications following reduction mammaplasty: a review of 3538 cases from the 2005\u20132010 NSQIP data sets","volume":"34","author":"Fischer","year":"2014","journal-title":"Aesthet Surg J"},{"key":"bib2-20260601","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/01.PRS.0000160695.33457.DB","article-title":"Analysis of breast reduction complications derived from the BRAVO study","volume":"115","author":"Cunningham","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"bib3-20260601","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PRS.0000000000010071","article-title":"Tranexamic acid use in breast surgery: a systematic review and meta-analysis","volume":"151","author":"Liechti","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"bib4-20260601","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/bjs.9878","article-title":"Randomized clinical trial of topical tranexamic acid after reduction mammoplasty","volume":"102","author":"Ausen","year":"2015","journal-title":"Br J Surg"},{"key":"bib5-20260601","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/SCS.0000000000002250","article-title":"The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery","volume":"27","author":"Murphy","year":"2016","journal-title":"J Craniofac Surg"},{"key":"bib6-20260601","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PRS.0000000000003926","article-title":"The role of tranexamic acid in plastic surgery: review and technical considerations","volume":"141","author":"Rohrich","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"bib7-20260601","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jss.2014.08.026","article-title":"Efficacy of hemostatic matrix and microporous polysaccharide hemospheres","volume":"193","author":"Lewis","year":"2015","journal-title":"J Surg Res"},{"key":"bib8-20260601","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21037\/gs-23-297","article-title":"Clinical effectiveness of microporous polysaccharide hemospheres in mastectomy for patients with breast cancer","volume":"13","author":"Shinden","year":"2024","journal-title":"Gland Surg"},{"key":"bib9-20260601","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5152\/balkanmedj.2012.005","article-title":"Microporous polysaccharide hemospheres and seroma formation after mastectomy and axillary dissection in rats","volume":"29","author":"Egeli","year":"2012","journal-title":"Balkan Med J"},{"key":"bib10-20260601","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1016\/j.clbc.2022.07.015","article-title":"Effect of microporous polysaccharide particles in patients undergoing mastectomy","volume":"22","author":"Selfridge","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"bib11-20260601","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12885-019-5293-1","article-title":"Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial","volume":"19","author":"Suarez-Kelly","year":"2019","journal-title":"BMC Cancer"},{"issue":"6S Suppl 4","key":"bib12-20260601","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1097\/SAP.0000000000003296","article-title":"The usage of intravenous tranexamic acid in reduction mammaplasty safely reduces hematoma rates","volume":"90","author":"Om","year":"2023","journal-title":"Ann Plast Surg"},{"key":"bib13-20260601","first-page":"277","article-title":"Accuracy of visually estimated blood loss in surgical sponges by members of the surgical team","volume":"87","author":"Kollberg","year":"2019","journal-title":"AANA J"},{"key":"bib14-20260601","doi-asserted-by":"crossref","first-page":"e0240808","DOI":"10.1371\/journal.pone.0240808","article-title":"Do we visually estimate intra-operative blood loss better with white or green sponges and is the deviation from the real blood loss clinically acceptable? Results from a simulated scenario study","volume":"15","author":"Piekarski","year":"2020","journal-title":"PloS One"},{"key":"bib15-20260601","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/bjs5.50248","article-title":"Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial","volume":"4","author":"Ausen","year":"2020","journal-title":"BJS Open"},{"key":"bib16-20260601","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lio2.770","article-title":"Effect of microporous polysaccharide hemospheres on anterolateral thigh free flap donor site complications","volume":"7","author":"David","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"bib17-20260601","first-page":"177","article-title":"The safety and efficacy of microporous polysaccharide hemospheres in terms of the complication rates in total hip arthroplasty for femoral neck fractures: a control-matched retrospective cohort","volume":"14","author":"Pidgaiska","year":"2024","journal-title":"Life (Basel)"},{"key":"bib18-20260601","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jor.2018.11.006","article-title":"Microporous polysaccharide hemosphere efficacy and safety in primary total knee arthroplasty","volume":"16","author":"Gleason","year":"2019","journal-title":"J Orthop"},{"key":"bib19-20260601","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review","volume":"47","author":"Ng","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"bib20-20260601","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1213\/ANE.0000000000004389","article-title":"Tranexamic acid for acute hemorrhage: a narrative review of landmark studies and a critical reappraisal of its use over the last decade","volume":"129","author":"Lier","year":"2019","journal-title":"Anesth Analg"},{"key":"bib21-20260601","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/sur.2007.033","article-title":"Microporous polysaccharide hemospheres do not enhance abdominal infection in a rat model compared with gelatin matrix","volume":"10","author":"Ereth","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"bib22-20260601","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.arth.2018.02.068","article-title":"Pharmacologic hemostatic agents in total joint arthroplasty\u2014a cost-effectiveness analysis","volume":"33","author":"Ramkumar","year":"2018","journal-title":"J Arthroplasty"},{"issue":"9 Suppl","key":"bib23-20260601","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","article-title":"The James A. Rand Young Investigator's award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?","volume":"31","author":"Fillingham","year":"2016","journal-title":"J Arthroplasty"},{"key":"bib24-20260601","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/CEOR.S88698","article-title":"Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats","volume":"7","author":"Martyn","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"bib25-20260601","first-page":"173","article-title":"Review of evidence supporting the Arista\u2122 absorbable powder hemostat","volume":"17","author":"LyBarger","year":"2024","journal-title":"Med Devices (Auckl)"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:00:21Z","timestamp":1780322421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":25,"journal-issue":{"issue":"6S","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004586","relation":{},"ISSN":["0148-7043","1536-3708"],"issn-type":[{"value":"0148-7043","type":"print"},{"value":"1536-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}